A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment

@article{Tait2016ASR,
  title={A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment},
  author={R. Tait and D. Caldicott and D. Mountain and S. Hill and S. Lenton},
  journal={Clinical Toxicology},
  year={2016},
  volume={54},
  pages={1 - 13}
}
  • R. Tait, D. Caldicott, +2 authors S. Lenton
  • Published 2016
  • Medicine
  • Clinical Toxicology
  • Abstract Context: Synthetic cannabinoids (SCs) such as “Spice”, “K2”, etc. are widely available via the internet despite increasing legal restrictions. Currently, the prevalence of use is typically low in the general community (<1%) although it is higher among students and some niche groups subject to drug testing. Early evidence suggests that adverse outcomes associated with the use of SCs may be more prevalent and severe than those arising from cannabis consumption. Objectives: To identify… CONTINUE READING
    Focus on cannabinoids and synthetic cannabinoids
    • 43
    Role of cannabis in cardiovascular disorders.
    • 57
    • Highly Influenced
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 181 REFERENCES
    Spice drugs as a new trend: mode of action, identification and legislation.
    • 312
    • Highly Influential
    Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2
    • 223